“Secukinumab’s Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment”. SKIN The Journal of Cutaneous Medicine, vol. 2, no. S1, Feb. 2018, p. S18, https://doi.org/10.25251/skin.2.supp.18.